ReviewTherapeutic advances in hematology2018

Updates in clinical trial data of extended half-life recombinant factor IX products for the treatment of haemophilia B.

Johnny N MahlanguPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.